Alps Advisors Inc

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-30
Total Holdings
1,028
Total Value
17244920728
Accession Number
0001398344-25-008194
Form Type
13F-HR
Manager Name
Alps Advisors Inc
Data Enrichment
97% identified
996 identified32 unidentified

Holdings

1,028 positions
Manager:
Search and click to pin securities to the top
Page 29 of 50
H5012F103
Shares:
293134
Value:
$627.3M
Dell Technologies Inc.
Shares:
6880(-5.7%)
Value:
$627.1M(-25.4%)
SANDSTORM GOLD LTD
Shares:
82604
Value:
$623.7M
MAC Copper Ltd
Shares:
63865(-7.6%)
Value:
$609.3M(-17.0%)
Ameresco, Inc.
Shares:
50285(+2.1%)
Value:
$607.4M(-47.4%)
DELUXE CORP
Shares:
38377(-3.5%)
Value:
$606.7M(-32.5%)
TARGET CORP
Shares:
5809(-36.5%)
Value:
$606.2M(-51.0%)
Arcus Biosciences, Inc.
Shares:
77107(+4.2%)
Value:
$605.3M(-45.1%)
NEW PACIFIC METALS CORP
Shares:
546324(+1658.6%)
Value:
$603.7M(+1546.8%)
LINDE PLC
Shares:
1288(+52.8%)
Value:
$599.7M(+69.9%)
WELLTOWER INC.
Shares:
3800(+35.5%)
Value:
$582.2M(+64.7%)
Day One Biopharmaceuticals, Inc.
Shares:
73343(-10.1%)
Value:
$581.6M(-43.7%)
Pharvaris N.V.
Shares:
36633(-16.1%)
Value:
$575.1M(-31.3%)
GOLDMAN SACHS GROUP INC
Shares:
1049(+35.7%)
Value:
$573.1M(+29.5%)
Praxis Precision Medicines, Inc.
Shares:
14938(-0.8%)
Value:
$565.7M(-51.2%)
OneMain Holdings, Inc.
Shares:
11452(-3.5%)
Value:
$559.8M(-9.5%)
Mineralys Therapeutics, Inc.
Shares:
34664(-13.9%)
Value:
$550.5M(+11.1%)
Intellia Therapeutics, Inc.
Shares:
77328(-6.1%)
Value:
$549.8M(-42.7%)
Replimune Group, Inc.
Shares:
56328(-7.5%)
Value:
$549.2M(-25.6%)
Xencor Inc
Shares:
51459(-9.1%)
Value:
$547.5M(-57.9%)